Stillen Tab.

DRUG4 trials

Sponsors

Dong-A ST Co., Ltd., Chong Kun Dang Pharmaceutical, Mather's Pharm. Co., Ltd.

Conditions

Acute GastritisChronic GastritisGastritis

Phase 3

A Study to Evaluate the Efficacy and Safety of DA-5204

Dong-A ST Co., Ltd.Acute Gastritis, Chronic Gastritis

Start: 2014-04-30End: 2014-11-30Updated: 2014-11-04

Phase 4

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

CompletedNCT01817556

Dong-A ST Co., Ltd.Acute Gastritis, Chronic Gastritis

Start: 2012-10-31End: 2013-10-31Updated: 2021-04-15

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

CompletedNCT02356679

Chong Kun Dang PharmaceuticalAcute Gastritis, Chronic Gastritis

Start: 2014-08-31End: 2015-06-30Updated: 2015-08-24

Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis

Not yet recruitingNCT07631065

Mather's Pharm. Co., Ltd.Acute Gastritis, Chronic Gastritis, Gastritis

Start: 2026-06-01End: 2028-02-01Target: 470Updated: 2026-06-05

Related Papers

Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study

Journal of Korean Medical Science2017-01-0113 citations